secwatch.observer — SEC 8-K summary
======================================

Issuer:     GYRE THERAPEUTICS, INC. (GYRE)
CIK:        0001124105
Form:       8-K
Filed at:   2024-11-27T23:59:59+00:00
Accession:  0001140361-24-047980
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gyre Therapeutics enters $50M at-the-market equity offering with Jefferies
--------------------------------------------------------------------------

- ATM agreement filed Nov 27, 2024; up to $50M of common stock may be sold.
- Jefferies LLC acts as sales agent; commission up to 3.0% of gross proceeds.
- Proceeds intended for R&D, manufacturing, scale-up, and general corporate purposes.
- Sales may be made on Nasdaq under effective S-3 shelf registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124105/000114036124047980/0001140361-24-047980-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124105/000114036124047980/ny20036484x4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-047980

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer